Silke Gillessen
希尔克·吉勒森
MD
Professor of Oncology; Head, Prostate Cancer Research Group肿瘤学教授；前列腺癌研究组负责人
👥Biography 个人简介
Silke Gillessen is a senior leader in advanced prostate cancer oncology and a key coordinator of the STAMPEDE platform trial, the most influential prostate cancer trial of the modern era. Her work spans mHSPC and mCRPC treatment optimization, international guideline development, and advocacy for global trial collaboration.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
STAMPEDE Platform Trial Coordination
Served as a principal coordinator of the STAMPEDE adaptive platform trial, which has generated multiple positive arms including abiraterone, enzalutamide, and docetaxel combinations, fundamentally changing mHSPC treatment paradigms.
Representative Works 代表性著作
Abiraterone Acetate plus Prednisolone with or without Enzalutamide for Patients with Metastatic Prostate Cancer (STAMPEDE)
The Lancet (2021)
STAMPEDE arm demonstrating combination hormonal intensification strategies in metastatic prostate cancer with major survival benefit.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 希尔克·吉勒森 的研究动态
Follow Silke Gillessen's research updates
留下邮箱，当我们发布与 Silke Gillessen（Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment